A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

NCT04657003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

938

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Overweight
Obesity

Interventions

DRUG: Tirzepatide
OTHER: Placebo

Sponsor

Eli Lilly and Company